Organism 73797 - Dracaena angustifolia (AGAVACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon86265
FamilyAGAVACEAE
GenusDRACAENA
SpeciesANGUSTIFOLIA
Species authorityROXB.
Subspecies
Subspecies authority
Comment
CitationTRAN,QL: TEZUKA,Y: BANSKOTA,AH: TRAN,QK: SAIKI,I: KADOTA,S:. (2001). NEW SPIROSTANOL STEROIDS AND STEROIDAL SAPONINS FROM ROOTS AND RHIZOMES OF DRACAENA ANGUSTIFOLIA AND THEIR ANTIPROLIFERATIVE ACTIVITY.. 64(9)
Geographical areaSOUTHEASTERN ASIA
CountryVIETNAM

Experiments

Filters
Worktypes (9)
48
18
10
10
10
10
8
2
1
No match
Pharmacology (2)
50
19
No match
Compounds (19)
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
No match
69 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
283118
VOUCHER SPECIMEN REPORTED FOR
Dracaena angustifolia (AGAVACEAE)
283119
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283120
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
283121
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(R):
283122
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):NAMOGENIN A,25(R):
283123
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):NAMOGENIN A,25(R):
283124
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):NAMOGENIN A,25(R):
283125
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN A,25(S):
283126
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN B
283127
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN CNAMOGENIN B
283128
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN CNAMOGENIN B
283129
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN CNAMOGENIN B
283130
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMOGENIN C
283131
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
283132
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
283133
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
283134
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN A
283135
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283136
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283137
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283138
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN B
283139
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283140
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283141
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283142
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN C
283143
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283144
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283145
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283146
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN D
283147
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
283148
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
283149
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
283150
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN E
283151
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
283152
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
283153
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
283154
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
NAMONIN F
283155
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
283156
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
283157
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
283158
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]-ALPHA-L-ARABINOPYRANOSIDE}-24-O-BETA-D-FUCOPYRANOSIDE
283159
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283160
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283161
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283162
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-24-O-BETA-D-FUCOPYRANOSIDE
283163
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283164
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283165
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283166
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-{[2-3-4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL(1-2)]-[BETA-D-XYLOPYRANOSYL(1-3)]}-ALPHA-L-ARABINOPYRANOSIDE
283167
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
283168
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
283169
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
283170
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-23(S)-24(S)-TETROL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)}-ALPHA-L-ARABINOPYRANOSIDE
283171
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE
283172
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE
283173
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE
283174
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
FUROSTA-5-20(22)-25(27)-TRIEN-1-BETA-3-BETA-26-TRIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-ALPHA-L-ARABINOPYRANOSIDE]-26-O-BETA-D-GLUCOPYRANOSIDE
283175
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283176
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283177
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283178
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-ALPHA-L-ARABINOPYRANOSIDE
283179
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283180
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283181
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283182
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
SPIROSTA-5-25(27)-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283183
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283184
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283185
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
283186
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Dracaena angustifolia (AGAVACEAE)
PREGNA-5-16-DIEN-1-BETA-3-BETA-DIOL-1-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-ALPHA-L-ARABINOPYRANOSIDE
Show SPARQL Queries (1)